Gammaven 5gm Infusion is a medical treatment that aims to enhance the body's natural immune system, reducing the chances of infection for individuals with weakened immune systems. This infusion is derived from healthy human blood containing specific antibodies that aid in combatting infections effectively.

Research has demonstrated the efficacy of Gammaven 5gm Infusion in safeguarding bone marrow transplant patients aged over 20 during the initial 100 days post-transplant. It is particularly beneficial for individuals with compromised antibody production capability, which elevates their vulnerability to infections. By providing essential antibodies that the body may not generate independently, this therapy equips both children and adults with enhanced infection-fighting abilities.

Administered through injections, Gammaven 5gm Infusion necessitates close monitoring by healthcare professionals post-administration to detect any potential side effects. Some individuals might experience injection site reactions such as swelling, redness, pain, itching, bruising, or rash, as well as flushing sensations. Patients are advised to promptly report any adverse reactions to their healthcare provider for appropriate management.

Before undergoing Gammaven 5gm Infusion, individuals should disclose any blood clotting issues or recent/pending vaccinations to their healthcare provider. Due to limited information regarding its safety during pregnancy or breastfeeding, it is crucial to seek guidance from a medical professional prior to using this medication.